Urticaria is commonly known as rubella. It is a localized edema response due to dilation of the skin and mucosal small blood vessels and increased permeability. It usually subsides within 2 to 24 hours, but new rashes occur repeatedly. The course of the disease is delayed for several days to several months. More common in clinically.

The global market for Urticaria Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Urticaria Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Urticaria Drug by region & country, by Type, and by Application.

The Urticaria Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urticaria Drug.

Market Segmentation

Scope of Urticaria Drug - Market Report

Report Metric	Details
Report Name	Urticaria Drug - Market
CAGR	5%
Segment by Type:	Acute Urticaria Chronic Urticaria
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson and Johnson Services, Amneal Pharmaceuticals, Pfizer, Taro Pharmaceutical Industries Novartis AG, Akorn, Teva Pharmaceutical Industries, Genentech, Xolair
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Urticaria Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Urticaria Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Urticaria Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Urticaria Drug - Market report?

Ans: The main players in the Urticaria Drug - Market are Johnson and Johnson Services, Amneal Pharmaceuticals, Pfizer, Taro Pharmaceutical Industries Novartis AG, Akorn, Teva Pharmaceutical Industries, Genentech, Xolair

What are the Application segmentation covered in the Urticaria Drug - Market report?

Ans: The Applications covered in the Urticaria Drug - Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

What are the Type segmentation covered in the Urticaria Drug - Market report?

Ans: The Types covered in the Urticaria Drug - Market report are Acute Urticaria, Chronic Urticaria

1 Market Overview

1.1 Urticaria Drug Product Introduction

1.2 Global Urticaria Drug Market Size Forecast

1.2.1 Global Urticaria Drug Sales Value (2019-2030)

1.2.2 Global Urticaria Drug Sales Volume (2019-2030)

1.2.3 Global Urticaria Drug Sales Price (2019-2030)

1.3 Urticaria Drug Market Trends & Drivers

1.3.1 Urticaria Drug Industry Trends

1.3.2 Urticaria Drug Market Drivers & Opportunity

1.3.3 Urticaria Drug Market Challenges

1.3.4 Urticaria Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Urticaria Drug Players Revenue Ranking (2023)

2.2 Global Urticaria Drug Revenue by Company (2019-2024)

2.3 Global Urticaria Drug Players Sales Volume Ranking (2023)

2.4 Global Urticaria Drug Sales Volume by Company Players (2019-2024)

2.5 Global Urticaria Drug Average Price by Company (2019-2024)

2.6 Key Manufacturers Urticaria Drug Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Urticaria Drug Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Urticaria Drug

2.9 Urticaria Drug Market Competitive Analysis

2.9.1 Urticaria Drug Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Urticaria Drug Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urticaria Drug as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Acute Urticaria

3.1.2 Chronic Urticaria

3.2 Global Urticaria Drug Sales Value by Type

3.2.1 Global Urticaria Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Urticaria Drug Sales Value, by Type (2019-2030)

3.2.3 Global Urticaria Drug Sales Value, by Type (%) (2019-2030)

3.3 Global Urticaria Drug Sales Volume by Type

3.3.1 Global Urticaria Drug Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Urticaria Drug Sales Volume, by Type (2019-2030)

3.3.3 Global Urticaria Drug Sales Volume, by Type (%) (2019-2030)

3.4 Global Urticaria Drug Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital Pharmacies

4.1.2 Retail Pharmacies

4.1.3 Online Pharmacies

4.1.4 Others

4.2 Global Urticaria Drug Sales Value by Application

4.2.1 Global Urticaria Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Urticaria Drug Sales Value, by Application (2019-2030)

4.2.3 Global Urticaria Drug Sales Value, by Application (%) (2019-2030)

4.3 Global Urticaria Drug Sales Volume by Application

4.3.1 Global Urticaria Drug Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Urticaria Drug Sales Volume, by Application (2019-2030)

4.3.3 Global Urticaria Drug Sales Volume, by Application (%) (2019-2030)

4.4 Global Urticaria Drug Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Urticaria Drug Sales Value by Region

5.1.1 Global Urticaria Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Urticaria Drug Sales Value by Region (2019-2024)

5.1.3 Global Urticaria Drug Sales Value by Region (2025-2030)

5.1.4 Global Urticaria Drug Sales Value by Region (%), (2019-2030)

5.2 Global Urticaria Drug Sales Volume by Region

5.2.1 Global Urticaria Drug Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Urticaria Drug Sales Volume by Region (2019-2024)

5.2.3 Global Urticaria Drug Sales Volume by Region (2025-2030)

5.2.4 Global Urticaria Drug Sales Volume by Region (%), (2019-2030)

5.3 Global Urticaria Drug Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Urticaria Drug Sales Value, 2019-2030

5.4.2 North America Urticaria Drug Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Urticaria Drug Sales Value, 2019-2030

5.5.2 Europe Urticaria Drug Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Urticaria Drug Sales Value, 2019-2030

5.6.2 Asia Pacific Urticaria Drug Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Urticaria Drug Sales Value, 2019-2030

5.7.2 South America Urticaria Drug Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Urticaria Drug Sales Value, 2019-2030

5.8.2 Middle East & Africa Urticaria Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Urticaria Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Urticaria Drug Sales Value

6.2.1 Key Countries/Regions Urticaria Drug Sales Value, 2019-2030

6.2.2 Key Countries/Regions Urticaria Drug Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Urticaria Drug Sales Value, 2019-2030

6.3.2 United States Urticaria Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Urticaria Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Urticaria Drug Sales Value, 2019-2030

6.4.2 Europe Urticaria Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Urticaria Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Urticaria Drug Sales Value, 2019-2030

6.5.2 China Urticaria Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Urticaria Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Urticaria Drug Sales Value, 2019-2030

6.6.2 Japan Urticaria Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Urticaria Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Urticaria Drug Sales Value, 2019-2030

6.7.2 South Korea Urticaria Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Urticaria Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Urticaria Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Urticaria Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Urticaria Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Urticaria Drug Sales Value, 2019-2030

6.9.2 India Urticaria Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Urticaria Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Johnson and Johnson Services

7.1.1 Johnson and Johnson Services Company Information

7.1.2 Johnson and Johnson Services Introduction and Business Overview

7.1.3 Johnson and Johnson Services Urticaria Drug Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Johnson and Johnson Services Urticaria Drug Product Offerings

7.1.5 Johnson and Johnson Services Recent Development

7.2 Amneal Pharmaceuticals

7.2.1 Amneal Pharmaceuticals Company Information

7.2.2 Amneal Pharmaceuticals Introduction and Business Overview

7.2.3 Amneal Pharmaceuticals Urticaria Drug Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Amneal Pharmaceuticals Urticaria Drug Product Offerings

7.2.5 Amneal Pharmaceuticals Recent Development

7.3 Pfizer

7.3.1 Pfizer Company Information

7.3.2 Pfizer Introduction and Business Overview

7.3.3 Pfizer Urticaria Drug Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Pfizer Urticaria Drug Product Offerings

7.3.5 Pfizer Recent Development

7.4 Taro Pharmaceutical Industries Novartis AG

7.4.1 Taro Pharmaceutical Industries Novartis AG Company Information

7.4.2 Taro Pharmaceutical Industries Novartis AG Introduction and Business Overview

7.4.3 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Offerings

7.4.5 Taro Pharmaceutical Industries Novartis AG Recent Development

7.5 Akorn

7.5.1 Akorn Company Information

7.5.2 Akorn Introduction and Business Overview

7.5.3 Akorn Urticaria Drug Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Akorn Urticaria Drug Product Offerings

7.5.5 Akorn Recent Development

7.6 Teva Pharmaceutical Industries

7.6.1 Teva Pharmaceutical Industries Company Information

7.6.2 Teva Pharmaceutical Industries Introduction and Business Overview

7.6.3 Teva Pharmaceutical Industries Urticaria Drug Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Teva Pharmaceutical Industries Urticaria Drug Product Offerings

7.6.5 Teva Pharmaceutical Industries Recent Development

7.7 Genentech

7.7.1 Genentech Company Information

7.7.2 Genentech Introduction and Business Overview

7.7.3 Genentech Urticaria Drug Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Genentech Urticaria Drug Product Offerings

7.7.5 Genentech Recent Development

7.8 Xolair

7.8.1 Xolair Company Information

7.8.2 Xolair Introduction and Business Overview

7.8.3 Xolair Urticaria Drug Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Xolair Urticaria Drug Product Offerings

7.8.5 Xolair Recent Development

8 Industry Chain Analysis

8.1 Urticaria Drug Industrial Chain

8.2 Urticaria Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Urticaria Drug Sales Model

8.5.2 Sales Channel

8.5.3 Urticaria Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Johnson And Johnson Services

Amneal Pharmaceuticals

Pfizer Inc

Taro Pharmaceutical Industries Novartis AG

Akorn

Teva Pharmaceutical Industries

Genentech Inc

Xolair

List of Tables

Table 1. Urticaria Drug Market Trends

Table 2. Urticaria Drug Market Drivers & Opportunity

Table 3. Urticaria Drug Market Challenges

Table 4. Urticaria Drug Market Restraints

Table 5. Global Urticaria Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Urticaria Drug Revenue Market Share by Company (2019-2024)

Table 7. Global Urticaria Drug Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Urticaria Drug Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Urticaria Drug Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Urticaria Drug Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Urticaria Drug Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Urticaria Drug

Table 13. Global Urticaria Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urticaria Drug as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Urticaria Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Urticaria Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Urticaria Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Urticaria Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Urticaria Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Urticaria Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Urticaria Drug Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Urticaria Drug Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Urticaria Drug Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Urticaria Drug Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Urticaria Drug Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Urticaria Drug Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Urticaria Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Urticaria Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Urticaria Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Urticaria Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Urticaria Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Urticaria Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Urticaria Drug Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Urticaria Drug Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Urticaria Drug Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Urticaria Drug Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Urticaria Drug Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Urticaria Drug Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Urticaria Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Urticaria Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Urticaria Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Urticaria Drug Sales Value by Region (2019-2024) & (%)

Table 44. Global Urticaria Drug Sales Value by Region (2025-2030) & (%)

Table 45. Global Urticaria Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Urticaria Drug Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Urticaria Drug Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Urticaria Drug Sales Volume by Region (2019-2024) & (%)

Table 49. Global Urticaria Drug Sales Volume by Region (2025-2030) & (%)

Table 50. Global Urticaria Drug Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Urticaria Drug Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Urticaria Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Urticaria Drug Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Urticaria Drug Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Urticaria Drug Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Urticaria Drug Sales Volume, (2025-2030) & (K Units)

Table 57. Johnson and Johnson Services Company Information

Table 58. Johnson and Johnson Services Introduction and Business Overview

Table 59. Johnson and Johnson Services Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Johnson and Johnson Services Urticaria Drug Product Offerings

Table 61. Johnson and Johnson Services Recent Development

Table 62. Amneal Pharmaceuticals Company Information

Table 63. Amneal Pharmaceuticals Introduction and Business Overview

Table 64. Amneal Pharmaceuticals Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Amneal Pharmaceuticals Urticaria Drug Product Offerings

Table 66. Amneal Pharmaceuticals Recent Development

Table 67. Pfizer Company Information

Table 68. Pfizer Introduction and Business Overview

Table 69. Pfizer Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Pfizer Urticaria Drug Product Offerings

Table 71. Pfizer Recent Development

Table 72. Taro Pharmaceutical Industries Novartis AG Company Information

Table 73. Taro Pharmaceutical Industries Novartis AG Introduction and Business Overview

Table 74. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Offerings

Table 76. Taro Pharmaceutical Industries Novartis AG Recent Development

Table 77. Akorn Company Information

Table 78. Akorn Introduction and Business Overview

Table 79. Akorn Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Akorn Urticaria Drug Product Offerings

Table 81. Akorn Recent Development

Table 82. Teva Pharmaceutical Industries Company Information

Table 83. Teva Pharmaceutical Industries Introduction and Business Overview

Table 84. Teva Pharmaceutical Industries Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Teva Pharmaceutical Industries Urticaria Drug Product Offerings

Table 86. Teva Pharmaceutical Industries Recent Development

Table 87. Genentech Company Information

Table 88. Genentech Introduction and Business Overview

Table 89. Genentech Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Genentech Urticaria Drug Product Offerings

Table 91. Genentech Recent Development

Table 92. Xolair Company Information

Table 93. Xolair Introduction and Business Overview

Table 94. Xolair Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Xolair Urticaria Drug Product Offerings

Table 96. Xolair Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Urticaria Drug Downstream Customers

Table 100. Urticaria Drug Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Urticaria Drug Product Picture

Figure 2. Global Urticaria Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Urticaria Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Urticaria Drug Sales Volume (2019-2030) & (K Units)

Figure 5. Global Urticaria Drug Sales Price (2019-2030) & (US$/Unit)

Figure 6. Urticaria Drug Report Years Considered

Figure 7. Global Urticaria Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Urticaria Drug Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Urticaria Drug Revenue in 2023

Figure 10. Urticaria Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Acute Urticaria Picture

Figure 12. Chronic Urticaria Picture

Figure 13. Global Urticaria Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Urticaria Drug Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Urticaria Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Urticaria Drug Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Urticaria Drug Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospital Pharmacies

Figure 19. Product Picture of Retail Pharmacies

Figure 20. Product Picture of Online Pharmacies

Figure 21. Product Picture of Others

Figure 22. Global Urticaria Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Urticaria Drug Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Urticaria Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Urticaria Drug Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Urticaria Drug Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Urticaria Drug Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Urticaria Drug Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Urticaria Drug Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Urticaria Drug Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Urticaria Drug Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Urticaria Drug Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Urticaria Drug Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Urticaria Drug Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Urticaria Drug Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Urticaria Drug Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Urticaria Drug Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Urticaria Drug Sales Volume (%), (2019-2030)

Figure 39. United States Urticaria Drug Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Urticaria Drug Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Urticaria Drug Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Urticaria Drug Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Urticaria Drug Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Urticaria Drug Sales Value by Application (%), 2023 VS 2030

Figure 45. China Urticaria Drug Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Urticaria Drug Sales Value by Type (%), 2023 VS 2030

Figure 47. China Urticaria Drug Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Urticaria Drug Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Urticaria Drug Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Urticaria Drug Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Urticaria Drug Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Urticaria Drug Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Urticaria Drug Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Urticaria Drug Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Urticaria Drug Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Urticaria Drug Sales Value by Application (%), 2023 VS 2030

Figure 57. India Urticaria Drug Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Urticaria Drug Sales Value by Type (%), 2023 VS 2030

Figure 59. India Urticaria Drug Sales Value by Application (%), 2023 VS 2030

Figure 60. Urticaria Drug Industrial Chain

Figure 61. Urticaria Drug Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-8B8171

Thu Oct 24 00:00:00 UTC 2024

Add to Cart

Renal Cyst Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22B5643

Thu Oct 24 00:00:00 UTC 2024

Add to Cart

Folliculitis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-30X5600

Thu Oct 24 00:00:00 UTC 2024

Add to Cart

Cystic Acne Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5K5907

Thu Oct 24 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Urticaria Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-38Q7570

Urticaria Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Urticaria Drug - Market Size

Urticaria Drug - Market

Report Scope

Scope of Urticaria Drug - Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Urticaria Drug - Market report?

What are the Application segmentation covered in the Urticaria Drug - Market report?

What are the Type segmentation covered in the Urticaria Drug - Market report?

FEATURED COMPANIES

RELATED REPORTS